Business Description
Apotea AB (publ)
ISIN : SE0023313762
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | 1.16 | |||||
Interest Coverage | 24.5 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.03 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 36.49 | |||||
Days Sales Outstanding | 17.93 | |||||
Days Payable | 46.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.58 | |||||
Operating Margin % | 2.07 | |||||
Net Margin % | 1.6 | |||||
FCF Margin % | 1.74 | |||||
ROE % | 23.8 | |||||
ROA % | 6.72 | |||||
ROIC % | 11.04 | |||||
ROC (Joel Greenblatt) % | 19.65 | |||||
ROCE % | 20.31 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 98.48 | |||||
PE Ratio without NRI | 98.59 | |||||
PS Ratio | 1.57 | |||||
PB Ratio | 21.23 | |||||
Price-to-Tangible-Book | 24.25 | |||||
Price-to-Free-Cash-Flow | 90.46 | |||||
Price-to-Operating-Cash-Flow | 39.69 | |||||
EV-to-EBIT | 75.93 | |||||
EV-to-EBITDA | 38.07 | |||||
EV-to-Revenue | 1.58 | |||||
EV-to-FCF | 93.53 | |||||
Price-to-Graham-Number | 10.23 | |||||
Earnings Yield (Greenblatt) % | 1.32 | |||||
FCF Yield % | 1.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Apotea AB (publ) Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 5,450.2 | ||
EPS (TTM) (kr) | 0.836 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (kr) | 0 | ||
20-Day SMA (kr) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 76.75 - 97.52 | ||
Shares Outstanding (Mil) | 104.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Apotea AB (publ) Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Apotea AB (publ) Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Apotea AB (publ) Frequently Asked Questions
What is Apotea AB (publ)(OSTO:APOTEA)'s stock price today?
When is next earnings date of Apotea AB (publ)(OSTO:APOTEA)?
Does Apotea AB (publ)(OSTO:APOTEA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |